您的位置: 首页 > 农业专利 > 详情页

PRODUIT DE REMPLACEMENT DE FACTEUR DE COAGULATION SANGUINE POUR UTILISATION DANS LE TRAITEMENT PROPHYLACTIQUE OU THERAPEUTIQUE DES HEMORRAGIES
专利权人:
CSL BEHRING GMBH
发明人:
GROTTKE, OLIVER,HERZOG, EVA,HOCHLEITNER, GERALD
申请号:
CA3046406
公开号:
CA3046406A1
申请日:
2018.02.09
申请国别(地区):
CA
年份:
2018
代理人:
摘要:
The invention pertains to a blood coagulation factor replacement product for use in the treatment or prophylaxis of bleedings of patients having an acquired coagulation factor deficiency or for use in the treatment or prophylaxis of bleedings of patients having a congenital deficiency of a coagulation factor. Said product comprises at least isolated prothrombin (Factor II) and isolated Antithrombin III (ATIII), whereby the molar ratio between ATIII to Factor II is at least 1 : 30. By administration of said product the patient's risk for a thromboembolic complication is reduced.
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充